DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

173 hedge funds and large institutions have $1.4B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 27 closing their positions.

Holders
173
Holders Change
+1
Holders Change %
+0.58%
% of All Funds
3.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
28
Increased
56
Reduced
66
Closed
27
Calls
$1.51M
Puts
$4.79M
Net Calls
-$3.28M
Net Calls Change
+$5.06M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$52.1M
2
UBS Group
2
UBS Group
Switzerland
$48.5M
3
WP
3
Woodline Partners
California
$29.9M
4
CCM
4
CAAS Capital Management
New York
$10.8M
5
Goldman Sachs
5
Goldman Sachs
New York
$23.8M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$67.9M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$95.1M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$15.1M
4
BM
4
Bridger Management
New York
$0
5
State Street
5
State Street
Massachusetts
$62.1M
Name Market Value Shares Shares
Change 		Shares
Change %
RI
1
RTW Investments
New York
$160M 7,253,857 +26,444 +0.4%
BlackRock
2
BlackRock
New York
$133M 6,034,729 +235,875 +4%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$95.1M 4,317,623 -578,530 -12%
Vanguard Group
4
Vanguard Group
Pennsylvania
$73.9M 3,355,719 +116,657 +4%
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$67.9M 3,080,237 -1,000,000 -25%
State Street
6
State Street
Massachusetts
$62.1M 2,820,099 -319,274 -10%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$52.1M 2,366,225 +2,366,225 New
UBS Group
8
UBS Group
Switzerland
$48.5M 2,200,487 +1,112,278 +102%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$45.7M 2,072,217 -21,461 -1%
Citadel Advisors
10
Citadel Advisors
Florida
$41.9M 1,903,778 +198,906 +12%
EAM
11
Eagle Asset Management
Florida
$33.7M 1,530,652 -102,948 -6%
CS
12
Candriam SCA
Luxembourg
$31M 1,408,993 +199,787 +17%
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$30.2M 1,371,272 +312,817 +30%
WP
14
Woodline Partners
California
$29.9M 1,358,796 +885,189 +187%
ACM
15
Aquilo Capital Management
California
$29.9M 1,355,392 -19,384 -1%
CTA
16
Carillon Tower Advisers
Florida
$24.7M 1,120,359 -56,154 -5%
Goldman Sachs
17
Goldman Sachs
New York
$23.8M 1,078,873 +377,291 +54%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$22.8M 1,032,838 +88,359 +9%
Northern Trust
19
Northern Trust
Illinois
$18.4M 833,896 -15,966 -2%
PA
20
Perceptive Advisors
New York
$17.6M 800,000 – –
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
$17.6M 799,309 +206,171 +35%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$15.9M 722,512 – –
Renaissance Technologies
23
Renaissance Technologies
New York
$15.1M 686,878 -461,022 -40%
DCM
24
DAFNA Capital Management
California
$12.9M 587,756 +133,520 +29%
EA
25
Emerald Advisers
Pennsylvania
$12.9M 584,342 +66,858 +13%
1
2 3 4 5